Campbell D.K. Rogers
Chief Medical Officer & Executive VPDr. Campbell D.K. Rogers, M.D., F.A.C.C., serves as Member of Scientific Advisory Board at HeartBeam, Inc. since November 9, 2023. He has been the Chief Medical Officer at HeartFlow, Inc. since March 2012 and serves as its Executive Vice President. From July 2006 to March 2012, Dr. Rogers served as Chief Scientific Officer and Global Head of Research and Development at Cordis Corporation (currently part of Cardinal Health, Inc.), Johnson & Johnson, where he was responsible for leading investments and research in cardiovascular devices. Dr. Rogers served as the Chief Technology Officer of Cordis Corporation. He directed Cordis Corporation’s scientific and technical agenda and was responsible for leading investments and research in innovative cardiovascular and peripheral vascular technologies. He was a Principal Investigator for numerous interventional cardiology devices, diagnostic and pharmacology trials and is well published in the cardiovascular disease space. As Principal Investigator of Brigham and Women’s comprehensive interventional vascular biology laboratory, Dr. Rogers led for clinician education worldwide on the use of novel devices preceding clinical application. He has incredible experience and a wealth of knowledge with vast clinical, academic and industry experience. Dr. Rogers is a Clinical Associate, Massachusetts General Hospital and served as a Research Associate, Veteran’s Administration Medical Center, Mass. He is a veteran in the medical technology industry and healthcare field with experience in commercialization, development, education and research. He has extensive experience as a National Principal Investigator and Co-investigator of multi-center device and pharmacologic trials based in the cardiac catheterization lab. Dr. Rogers served as an Independent Director of InspireMD, Inc. since September 3, 2013 until 2022. He was associate professor of medicine at Harvard Medical School and the Harvard-M.I.T. Division of Health Sciences and Technology. He had been a Director of Corindus Vascular Robotics Inc. since February 04, 2016 until October 29, 2019. He served as Director of the Cardiac Catheterization Laboratory at Harvard Medical School. He served as a Director of Cardiac Catheterization Laboratory (CCL), Cardiovascular Division, Experimental Cardiovascular Interventional Laboratories at Brigham and Women's Hospital in Boston, Mass, where he oversaw all aspects of CCL activity, including faculty practice, clinical care, medical student, resident and cardiology fellow education and clinical research. He served on editorial boards, as an ad-hoc reviewer of numerous medical journals and as author of more than 100 publications and two books. Dr. Rogers has conducted extensive clinical research. He is the author of numerous journal articles, chapters and books in the area of coronary artery and other cardiovascular disease and is the recipient of many academic society honors. He is a visiting physician to various institutions in Beijing, China, Brazil and Hong Kong. He was the recipient of numerous research grant awards from the National Institute of Health and American Heart Association. He has significant experience in cardiovascular devices, as well as his familiarity with the operations of medical device companies. Dr. Rogers received his A.B. from Harvard College. He attended Clare College in Cambridge, England and received his M.D. from Harvard Medical School.
Positions
- Company NameHeartFlow, Inc.Stock CodeHTFLPositionChief Medical Officer & Executive VPColleagues
- JCJohn C.M. FarquharPresident, CEO & Director
- WCWilliam C. WeldonIndependent Chairman of the Board
- VVVikram VergheseChief Financial Officer
- JHJohn Henry StevensCo-Founder
- KCKathleen CareySenior Vice President of Operations
- WJWayne Joseph RileyIndependent Director
- TCTimothy C. BarabeIndependent Director
- CMCasey M. TanseyIndependent Director
